Lonza to sell capsules & health ingredients business for $3 billion in major strategic shift

Lonza implements streamlined operating model

Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy

BASF sells food and health performance ingredients business to Louis Dreyfus Company

Divestment is part of BASF’s strategic portfolio optimization

Lonza expands capsule manufacturing capacity in India and China

New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou

Lonza outlines strategy, new organizational structure and guidance

The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities

Lonza reports softer performance in Q1 2024

Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s

Evonik partners with Safic-Alcan to boost offering of advanced food ingredients

Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt

Lonza launches new capsule to deliver acid-sensitive API to the intestine

Innovative Capsugel Enprotect capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines

Lonza appoints Christian Seufert as President of CHI Division

Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses